Technology Transfer Tactics will be offering a webinar entitled "Antibody Patenting and Licensing Challenges in Light of Amgen v. Sanofi" on August 23, 2018 from 1:00 to 2:00 pm (ET). Patent Docs author Kevin E. Noonan of McDonnell Boehnen Hulbert & Berghoff LLP will address the following topics:
• Technology background
• Legal development
-- Enablement v. written description
-- Noelle v Ledermann
-- Centocor v. Abbott
-- AbbVie v. Janssen
-- Yeda v. Abbott
• Amgen v. Sanofi: the Federal Circuit clarifies written description for antibodies
-- Ariad v. Eli Lilly
• Implications on antibody patent scope
• Effects on licensing
• Alternative antibody embodiments
• Retroactivity
• Strategy going forward
-- Review and revision of pending patents
-- Claim construction
-- How faculty researchers can help
-- Use of third-parties for characterization
The registration fee for the webinar is $197. Those interested in registering for the webinar, can do so here.
Comments